Published in Mol Med on July 22, 2011
TRPV1 potentiates TGFβ-induction of corneal myofibroblast development through an oxidative stress-mediated p38-SMAD2 signaling loop. PLoS One (2013) 0.93
The heme oxygenase system suppresses perirenal visceral adiposity, abates renal inflammation and ameliorates diabetic nephropathy in Zucker diabetic fatty rats. PLoS One (2014) 0.80
Functional TRPV and TRPM channels in human preadipocytes. Pflugers Arch (2013) 0.79
Effect of mineralocorticoid treatment in mice with collecting duct-specific knockout of endothelin-1. Am J Physiol Renal Physiol (2015) 0.78
Stem cell-based cell therapy for glomerulonephritis. Biomed Res Int (2014) 0.77
Mechanisms by which heme oxygenase rescue renal dysfunction in obesity. Redox Biol (2014) 0.75
TRPV1 attenuates intracranial arteriole remodeling through inhibiting VSMC phenotypic modulation in hypertension. Histochem Cell Biol (2016) 0.75
Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell (2003) 25.94
Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (2000) 15.16
Molecular mechanisms of nociception. Nature (2001) 7.75
Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev (1999) 7.20
Growth factors and cytokines in wound healing. Wound Repair Regen (2009) 7.14
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice. Proc Natl Acad Sci U S A (2000) 3.48
Podocyte biology and response to injury. J Am Soc Nephrol (2002) 3.25
Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol (2003) 2.85
SMADs: mediators and regulators of TGF-beta signaling. Curr Opin Genet Dev (1998) 2.76
Molecular basis of renal fibrosis. Pediatr Nephrol (2000) 2.71
Immunosuppressive treatment protects against angiotensin II-induced renal damage. Am J Pathol (2002) 2.50
Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest (2001) 2.36
Transforming growth factor-beta and Smad signalling in kidney diseases. Nephrology (Carlton) (2005) 2.23
The epidemiology of chronic kidney disease. Kidney Int Suppl (2005) 2.01
Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol (2004) 1.76
Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways. J Biol Chem (2007) 1.73
Transforming growth factor-beta signal transduction in angiogenesis and vascular disorders. Chest (2005) 1.57
Deletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension. Hypertension (2008) 1.55
Lipopolysaccharide triggers late preconditioning against myocardial infarction via inducible nitric oxide synthase. Cardiovasc Res (2002) 1.51
Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol Endocrinol (2008) 1.41
Effects of cyclosporin A on the development of immune-mediated interstitial nephritis. Kidney Int (1988) 1.39
Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases. J Am Soc Nephrol (2005) 1.39
Transforming growth factor-beta-dependent events in vascular remodeling following arterial injury. J Vasc Res (2003) 1.14
The interrelationship between TGF-beta1 and nitric oxide is altered in salt-sensitive hypertension. Am J Physiol Renal Physiol (2003) 1.14
Secreted protein acidic and rich in cysteine deficiency ameliorates renal inflammation and fibrosis in angiotensin hypertension. Am J Pathol (2007) 1.12
Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension. Hypertension (2007) 1.10
VR1-mediated depressor effects during high-salt intake: role of anandamide. Hypertension (2005) 1.06
Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation. J Biol Chem (2004) 1.06
The enhancement of aminonucleoside nephrosis by the co-administration of protamine. Kidney Int (1987) 1.04
IL-1RI deficiency ameliorates early experimental renal interstitial fibrosis. Nephrol Dial Transplant (2009) 1.03
Transforming growth factor-beta blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarction. Endocrinology (2008) 1.01
Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy. Lab Invest (2006) 1.00
Alterations in TGF-beta1 expression in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2003) 1.00
Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension. Am J Physiol Renal Physiol (2009) 0.93
Endocannabinoid regulates blood pressure via activation of the transient receptor potential vanilloid type 1 in Wistar rats fed a high-salt diet. J Pharmacol Exp Ther (2007) 0.90
Increased transforming growth factor-beta production and gene expression by peripheral blood monocytes of hypertensive patients. Hypertension (1997) 0.89
Effects of diabetes and hypertension on macrophage infiltration and matrix expansion in the rat kidney. BMC Nephrol (2005) 0.84
Transforming growth factor-beta1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker. Nephrol Dial Transplant (2008) 0.81
Enhanced oxidative stress in kidneys of salt-sensitive hypertension: role of sensory nerves. Am J Physiol Heart Circ Physiol (2006) 0.80
Increased expression of transforming growth factor-beta and eosinophil infiltration is associated with the development of transplant arteriosclerosis in long-term surviving cardiac allografts. Transplantation (2003) 0.77
Growth factors and vascular wall. Int Angiol (1996) 0.76
Development of angiotensin II-induced hypertension: role of CGRP and its receptor. J Hypertens (2005) 2.00
Development of hypertension and kidney hypertrophy in transgenic mice overexpressing ARAP1 gene in the kidney. Hypertension (2006) 1.58
Deletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension. Hypertension (2008) 1.55
TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation (2005) 1.32
Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor. Hypertension (2002) 1.28
A novel mechanism contributing to development of Dahl salt-sensitive hypertension: role of the transient receptor potential vanilloid type 1. Hypertension (2005) 1.18
TRPV1 gene knockout impairs preconditioning protection against myocardial injury in isolated perfused hearts in mice. Am J Physiol Heart Circ Physiol (2007) 1.08
VR1-mediated depressor effects during high-salt intake: role of anandamide. Hypertension (2005) 1.06
Prevention of endothelin-1-induced increases in blood pressure: role of endogenous CGRP. Am J Physiol Heart Circ Physiol (2004) 1.02
Salt intake augments hypotensive effects of transient receptor potential vanilloid 4: functional significance and implication. Hypertension (2008) 0.98
Transient receptor potential vanilloid gene deletion exacerbates inflammation and atypical cardiac remodeling after myocardial infarction. Hypertension (2008) 0.97
N-oleoyldopamine, a novel endogenous capsaicin-like lipid, protects the heart against ischemia-reperfusion injury via activation of TRPV1. Am J Physiol Heart Circ Physiol (2008) 0.97
TRPV1-mediated protection against endotoxin-induced hypotension and mortality in rats. Am J Physiol Regul Integr Comp Physiol (2008) 0.97
Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors. Am J Physiol Regul Integr Comp Physiol (2009) 0.96
Diuresis and natriuresis caused by activation of VR1-positive sensory nerves in renal pelvis of rats. Hypertension (2005) 0.93
Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension. Am J Physiol Renal Physiol (2009) 0.93
Regulation of TRPV1 by a novel renally expressed rat TRPV1 splice variant. Am J Physiol Renal Physiol (2005) 0.91
Function and regulation of the vanilloid receptor in rats fed a high salt diet. J Hypertens (2003) 0.90
Endocannabinoid regulates blood pressure via activation of the transient receptor potential vanilloid type 1 in Wistar rats fed a high-salt diet. J Pharmacol Exp Ther (2007) 0.90
TRPV1-mediated diuresis and natriuresis induced by hypertonic saline perfusion of the renal pelvis. Am J Nephrol (2007) 0.88
Nanomechanical analysis of insulinoma cells after glucose and capsaicin stimulation using atomic force microscopy. Acta Pharmacol Sin (2011) 0.87
Hypotension induced by activation of the transient receptor potential vanilloid 4 channels: role of Ca2+-activated K+ channels and sensory nerves. J Hypertens (2010) 0.86
Gene transfer of endothelial NO synthase and manganese superoxide dismutase on arterial vascular cell adhesion molecule-1 expression and superoxide production in deoxycorticosterone acetate-salt hypertension. Arterioscler Thromb Vasc Biol (2002) 0.86
Increased GFR and renal excretory function by activation of TRPV1 in the isolated perfused kidney. Pharmacol Res (2008) 0.86
Impaired vasodilation in response to perivascular nerve stimulation in mesenteric arteries of TRPV1-null mutant mice. J Hypertens (2006) 0.86
Differential mechanisms mediating depressor and diuretic effects of anandamide. J Hypertens (2006) 0.86
Statins reduce connexin40 and connexin43 expression in atherosclerotic aorta of rabbits. Int J Cardiol (2005) 0.86
ET(A) receptor blockade prevents renal dysfunction in salt-sensitive hypertension induced by sensory denervation. Am J Physiol Heart Circ Physiol (2005) 0.85
Neural control of blood pressure: focusing on capsaicin-sensitive sensory nerves. Cardiovasc Hematol Disord Drug Targets (2007) 0.85
Investigation of angiotensin II type 1 receptor by atomic force microscopy with functionalized tip. Nanomedicine (2005) 0.85
High-salt-induced increase in blood pressure: role of capsaicin-sensitive sensory nerves. J Hypertens (2003) 0.83
P2Y2 receptors mediate ATP-induced resensitization of TRPV1 expressed by kidney projecting sensory neurons. Am J Physiol Regul Integr Comp Physiol (2010) 0.83
Increased depressor response to N-arachidonoyl-dopamine during high salt intake: role of the TRPV1 receptor. J Hypertens (2007) 0.82
Role of TRPV1 channels in renal haemodynamics and function in Dahl salt-sensitive hypertensive rats. Exp Physiol (2008) 0.82
Regulation of connexin expression after balloon injury: possible mechanisms for antiproliferative effect of statins. Am J Hypertens (2005) 0.82
Role of substance P in renal injury during DOCA-salt hypertension. Endocrinology (2012) 0.82
Probing membrane proteins using atomic force microscopy. J Cell Biochem (2006) 0.82
Function and regulation of epithelial sodium transporters in the kidney of a salt-sensitive hypertensive rat model. J Hypertens (2007) 0.81
In situ sensing and manipulation of molecules in biological samples using a nanorobotic system. Nanomedicine (2005) 0.81
Segmental regulation of sodium and water excretion by TRPV1 activation in the kidney. J Cardiovasc Pharmacol (2008) 0.81
TRPV1 ablation aggravates inflammatory responses and organ damage during endotoxic shock. Clin Vaccine Immunol (2013) 0.81
Transient receptor potential vanilloid subtype 1 channel mediated neuropeptide secretion and depressor effects: role of endoplasmic reticulum associated Ca2+ release receptors in rat dorsal root ganglion neurons. J Hypertens (2008) 0.80
Impairment in function and expression of transient receptor potential vanilloid type 4 in Dahl salt-sensitive rats: significance and mechanism. Hypertension (2010) 0.80
Enhanced oxidative stress in kidneys of salt-sensitive hypertension: role of sensory nerves. Am J Physiol Heart Circ Physiol (2006) 0.80
Role of the transient receptor potential vanilloid type 1 channel in renal inflammation induced by lipopolysaccharide in mice. Am J Physiol Regul Integr Comp Physiol (2012) 0.80
Interdependent regulation of afferent renal nerve activity and renal function: role of transient receptor potential vanilloid type 1, neurokinin 1, and calcitonin gene-related peptide receptors. J Pharmacol Exp Ther (2008) 0.80
Capsaicin sensitive-sensory nerves and blood pressure regulation. Curr Med Chem Cardiovasc Hematol Agents (2003) 0.80
Enhanced postmyocardial infarction fibrosis via stimulation of the transforming growth factor-beta-Smad2 signaling pathway: role of transient receptor potential vanilloid type 1 channels. J Hypertens (2010) 0.79
Ablation of transient receptor potential vanilloid 1 abolishes endothelin-induced increases in afferent renal nerve activity: mechanisms and functional significance. Hypertension (2009) 0.79
Increased salt sensitivity induced by sensory denervation: role of superoxide. Acta Pharmacol Sin (2004) 0.78
Cellular biophysical dynamics and ion channel activities detected by AFM-based nanorobotic manipulator in insulinoma β-cells. Nanomedicine (2012) 0.78
Atomic force microscopy as nanorobot. Methods Mol Biol (2011) 0.78
Enhanced salt sensitivity following shRNA silencing of neuronal TRPV1 in rat spinal cord. Acta Pharmacol Sin (2011) 0.78
The potential of TRPV1 agonists for treating ischemia/reperfusion-induced renal injuries. Curr Opin Investig Drugs (2009) 0.78
Inhibition of renin release by arachidonic acid metabolites, 12(s)-HPETE and 12-HETE: role of TRPV1 channels. Endocrinology (2011) 0.78
Function and regulation of endothelin-1 and its receptors in salt sensitive hypertension induced by sensory nerve degeneration. Hypertension (2002) 0.78
Effects of a high-salt diet on TRPV-1-dependent renal nerve activity in Dahl salt-sensitive rats. Am J Nephrol (2010) 0.77
Transient receptor potential vanilloid in blood pressure regulation. Curr Opin Nephrol Hypertens (2013) 0.76
Activation of the renin-angiotensin system in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. J Hypertens (2004) 0.76
Nanotechnology and membrane receptors: focus on angiotensin II receptors. Med Clin North Am (2007) 0.75
[The protective role of transient receptor potential vanilloid subtype 1 in post-myocardial infarction inflammation process.]. Zhonghua Xin Xue Guan Bing Za Zhi (2009) 0.75